• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡咯烷酮作为人类黑皮质素-4受体的强效功能拮抗剂。

Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptor.

作者信息

Jiang Wanlong, Tucci Fabio C, Tran Joe A, Fleck Beth A, Wen Jenny, Markison Stacy, Marinkovic Dragan, Chen Caroline W, Arellano Melissa, Hoare Sam R, Johns Michael, Foster Alan C, Saunders John, Chen Chen

机构信息

Department of Medicinal Chemistry, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, CA 92130, USA.

出版信息

Bioorg Med Chem Lett. 2007 Oct 15;17(20):5610-3. doi: 10.1016/j.bmcl.2007.07.097. Epub 2007 Aug 23.

DOI:10.1016/j.bmcl.2007.07.097
PMID:17822895
Abstract

A series of pyrrolidinones derived from phenylalaninepiperazines were synthesized and characterized as potent and selective antagonists of the melanocortin-4 receptor. In addition to their high binding affinities, these compounds displayed high functional potencies. 12a had a K(i) of 0.94 nM in binding and IC(50) of 21 nM in functional activity. 12a also demonstrated efficacy in a mouse cachexia model.

摘要

合成了一系列源自苯丙氨酸哌嗪的吡咯烷酮,并将其表征为强效且选择性的黑皮质素-4受体拮抗剂。除了具有高结合亲和力外,这些化合物还表现出高功能活性。12a的结合解离常数(K(i))为0.94 nM,功能活性的半数抑制浓度(IC(50))为21 nM。12a在小鼠恶病质模型中也显示出疗效。

相似文献

1
Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptor.吡咯烷酮作为人类黑皮质素-4受体的强效功能拮抗剂。
Bioorg Med Chem Lett. 2007 Oct 15;17(20):5610-3. doi: 10.1016/j.bmcl.2007.07.097. Epub 2007 Aug 23.
2
Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activity.吡咯烷酮作为具有抗恶病质活性的人促黑素皮质激素-4受体口服生物可利用拮抗剂。
Bioorg Med Chem. 2007 Aug 1;15(15):5166-76. doi: 10.1016/j.bmc.2007.05.026. Epub 2007 May 17.
3
Propionylpiperazines as human melanocortin-4 receptor ligands.
Bioorg Med Chem Lett. 2006 Sep 15;16(18):4800-3. doi: 10.1016/j.bmcl.2006.06.075. Epub 2006 Jul 7.
4
Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists.2-哌嗪-α-异丙基苄胺衍生物作为黑皮质素-4受体拮抗剂的药理学和药代动力学特征
Bioorg Med Chem. 2008 May 15;16(10):5606-18. doi: 10.1016/j.bmc.2008.03.072. Epub 2008 Apr 1.
5
Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.吡咯烷非对映异构体作为人促黑素皮质素-4受体强效功能性激动剂和拮抗剂的鉴定与表征
Bioorg Med Chem Lett. 2008 Jan 1;18(1):129-36. doi: 10.1016/j.bmcl.2007.10.115. Epub 2007 Nov 4.
6
4-{(2R)-[3-Aminopropionylamido]-3-(2,4-dichlorophenyl)propionyl}-1-{2-[(2-thienyl)ethylaminomethyl]phenyl}piperazine as a potent and selective melanocortin-4 receptor antagonist--design, synthesis, and characterization.4-{(2R)-[3-氨基丙酰氨基]-3-(2,4-二氯苯基)丙酰基}-1-{2-[(2-噻吩基)乙氨基甲基]苯基}哌嗪作为一种强效且选择性的黑皮质素-4受体拮抗剂——设计、合成及表征
J Med Chem. 2004 Dec 30;47(27):6821-30. doi: 10.1021/jm049278i.
7
Structure-activity relationship studies on a series of piperazinebenzylalcohols and their ketone and amine analogs as melanocortin-4 receptor ligands.
Bioorg Med Chem Lett. 2008 Sep 1;18(17):4817-22. doi: 10.1016/j.bmcl.2008.07.076. Epub 2008 Jul 25.
8
Synthesis and characterization of trans-4-(4-chlorophenyl)pyrrolidine-3-carboxamides of piperazinecyclohexanes as ligands for the melanocortin-4 receptor.作为黑素皮质素-4受体配体的哌嗪环己烷反式-4-(4-氯苯基)吡咯烷-3-甲酰胺的合成与表征
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6825-31. doi: 10.1016/j.bmcl.2007.10.032. Epub 2007 Oct 17.
9
Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptor.哌嗪苄胺作为人促黑素皮质激素-4受体的强效选择性拮抗剂。
Bioorg Med Chem Lett. 2004 Nov 15;14(22):5605-9. doi: 10.1016/j.bmcl.2004.08.055.
10
Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptor.苯基哌嗪和吡啶基哌嗪作为黑皮质素-4受体强效选择性拮抗剂的设计、合成、体外及体内特性研究
J Med Chem. 2007 Dec 13;50(25):6356-66. doi: 10.1021/jm701137s. Epub 2007 Nov 10.

引用本文的文献

1
Discovery of CRN04894: A Novel Potent Selective MC2R Antagonist.CRN04894的发现:一种新型强效选择性促肾上腺皮质激素释放激素受体2拮抗剂。
ACS Med Chem Lett. 2024 Mar 19;15(4):478-485. doi: 10.1021/acsmedchemlett.3c00514. eCollection 2024 Apr 11.
2
Pathophysiology of anorexia in the cancer cachexia syndrome.癌症恶病质综合征中厌食的病理生理学
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):287-302. doi: 10.1002/jcsm.12059. Epub 2015 Oct 27.
3
The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.
生长激素释放肽及生长激素释放肽受体激动剂治疗疾病动物模型的作用:疗效和机制。
Curr Pharm Des. 2012;18(31):4779-99. doi: 10.2174/138161212803216951.
4
Solid-phase synthesis of N-substituted pyrrolidinone-tethered N-substituted piperidines via Ugi reaction.通过乌吉反应固相合成N-取代吡咯烷酮连接的N-取代哌啶
J Comb Chem. 2010 Jul 12;12(4):566-70. doi: 10.1021/cc100054u.
5
Animal models of anorexia and cachexia.厌食症和恶病质的动物模型。
Expert Opin Drug Discov. 2009 Nov 1;4(11):1145-1155. doi: 10.1517/17460440903300842.
6
Update on melanocortin interventions for cachexia: progress toward clinical application.肥胖恶病质的黑素皮质素干预措施的最新进展:向临床应用的推进。
Nutrition. 2010 Feb;26(2):146-51. doi: 10.1016/j.nut.2009.07.003. Epub 2009 Dec 8.